In this issue:
- NZ asthma medication use patterns after publication of national guidelines
- US clinicians’ views of prescribing reliever budesonide-formoterol inhalers and SMART
- Identifying asthma research priorities
- Programme for difficult-to-treat asthma with obesity
- Persistent airflow limitation phenotype in asthma
- Complex interplay among asthma, atopic dermatitis and GORD
- Prenatal plastic-derived chemical/metabolite exposure and lung function/asthma risk
- Landscape fire smoke exposure in asthma ± laryngeal hypersensitivity
- Tezepelumab for severe uncontrolled asthma
- Relationship between asthma and severe COVID-19
- Difficult-to-treat asthma: implications from treatable traits
- Questionnaire for use in dysfunctional breathing
Please login below to download this issue (PDF)